These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35533602)

  • 41. Seizure activity in combined clozapine and ECT: a retrospective view.
    Cardwell BA; Nakai B
    Convuls Ther; 1995 Jun; 11(2):110-3. PubMed ID: 7552049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using ECT in schizophrenia: a review from a clinical perspective.
    Zervas IM; Theleritis C; Soldatos CR
    World J Biol Psychiatry; 2012 Feb; 13(2):96-105. PubMed ID: 21486108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Achieving stable remission with maintenance electroconvulsive therapy in a patient with treatment-resistant schizophrenia: A case report.
    Moeller S; Kalkwarf N; Lücke C; Ortiz D; Jahn S; Först C; Braun N; Philipsen A; Müller HHO
    Medicine (Baltimore); 2017 Dec; 96(48):e8813. PubMed ID: 29310360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia.
    Bhatia SC; Bhatia SK; Gupta S
    J ECT; 1998 Dec; 14(4):280-3. PubMed ID: 9871852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of ECT effects on clozapine plasma levels in patients with treatment-resistant schizophrenia: Pharmacokinetic evidence from a randomized clinical trial.
    Schoretsanitis G; Mendelowitz A; Malur C; Braga RJ; Schooler NR; John M; de Leon J; Kane JM; Petrides G
    Schizophr Res; 2020 Apr; 218():309-311. PubMed ID: 32107101
    [No Abstract]   [Full Text] [Related]  

  • 46. Nerve growth factor serum levels in treatment-resistant schizophrenic patients following electroconvulsive therapy.
    Pacitti F; Bersani G; Aloe L; Caredda M; Orsi P; Quartini A; Vitali M; Ceccanti M; Tirassa P; Fiore M; Iannitelli A
    Clin Ter; 2021; 171(1):e67-e74. PubMed ID: 33346332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.
    Greenhalgh J; Knight C; Hind D; Beverley C; Walters S
    Health Technol Assess; 2005 Mar; 9(9):1-156, iii-iv. PubMed ID: 15774232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients.
    Masoudzadeh A; Khalilian AR
    Pak J Biol Sci; 2007 Dec; 10(23):4287-90. PubMed ID: 19086588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
    Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
    J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia.
    Braga RJ; Petrides G
    J ECT; 2005 Jun; 21(2):75-83. PubMed ID: 15905747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Which are the best evidence-based therapeutic options for clozapine and ECT resistant schizophrenia? A case-report.
    Damiano RF; Avrichir BS; Melzer-Ribeiro DL; Sallet PC; Elkis H
    Psychiatry Res; 2021 Nov; 305():114248. PubMed ID: 34739952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electroconvulsive therapy for schizophrenia.
    Tharyan P; Adams CE
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000076. PubMed ID: 15846598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Augmentation of antipsychotics with electroconvulsive therapy in treatment-resistant schizophrenia patients with dominant negative symptoms: a pilot study of effectiveness.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Neuropsychobiology; 2014; 70(3):158-64. PubMed ID: 25358377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy of continuation and maintenance electroconvulsive therapy (c/m ECT) in the treatment of patients with therapy-resistant affective disorders: a retrospective analysis].
    Post T; Kemmler G; Krassnig T; Brugger A; Hausmann A
    Neuropsychiatr; 2015; 29(3):133-8. PubMed ID: 26092747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive Effects of Electroconvulsive Therapy in Schizophrenia: A Systematic Review.
    Vaccarino SR; Vaccarino AL
    J Clin Psychiatry; 2024 Jun; 85(2):. PubMed ID: 38836867
    [No Abstract]   [Full Text] [Related]  

  • 56. Review of electroconvulsive therapy practice from a tertiary Child and Adolescent Psychiatry Centre.
    Jacob P; Gogi PK; Srinath S; Thirthalli J; Girimaji S; Seshadri S; Sagar JV
    Asian J Psychiatr; 2014 Dec; 12():95-9. PubMed ID: 25440568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.
    Havaki-Kontaxaki BJ; Ferentinos PP; Kontaxakis VP; Paplos KG; Soldatos CR
    Clin Neuropharmacol; 2006; 29(1):52-6. PubMed ID: 16518135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS).
    Grover S; Shouan A; Chakrabarti S; Sahoo S; Mehra A
    Nord J Psychiatry; 2021 Aug; 75(6):397-405. PubMed ID: 33630681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elective combined electroconvulsive and clozapine therapy.
    James DV; Gray NS
    Int Clin Psychopharmacol; 1999 Mar; 14(2):69-72. PubMed ID: 10220120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis.
    Ahmed S; Khan AM; Mekala HM; Venigalla H; Ahmed R; Etman A; Esang M; Qureshi M
    Heliyon; 2017 Nov; 3(11):e00429. PubMed ID: 29264404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.